It is great to see some discussion again after a long silence from SH.
I agree that there is plenty of scope to get the word out in the bio tech space about how vulnerable they are and frankly remiss to not take up the tech that BCT offers to assure their tracking of specimens is state of the art given the potential for catastrophic errors.
I think that the company is stretched with their building product capacity in line with growing demand from new and potential customers while staying within the confines of limited finances. Once over the hump with some capital behind them
things may change.
Most long term SH and reasonable sized holders who took a wacking but hung on after Labcon and Covid are naturally apprehensive as we approach a big deal that may well ease the financial strain.
The low SP contributes to SH concern.
While time will tell soon the stress is palpable.
GLTALSH
It is great to see some discussion again after a long silence...
Add BCT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.6¢ |
Change
0.000(0.00%) |
Mkt cap ! $6.605M | |||
| Open | High | Low | Value | Volume |
| 0.6¢ | 0.6¢ | 0.6¢ | $600 | 100K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 10 | 3277381 | 0.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.6¢ | 431500 | 3 |
View Market Depth
| Last trade - 16.10pm 24/05/2024 (20 minute delay) ? |
|
|||||
|
Last
0.6¢ |
Change
0.000 ( 0.00 %) |
||||
| Open | High | Low | Volume | ||
| 0.6¢ | 0.6¢ | 0.6¢ | 90361 | ||
| Last updated 15.03pm 24/05/2024 ? | |||||
| BCT (ASX) Chart |